Range Low Price High Price Comment
30 days $1.41 $2.23 Friday, 17th Jan 2025 CLLS stock ended at $1.48. This is 1.99% less than the trading day before Thursday, 16th Jan 2025. During the day the stock fluctuated 4.45% from a day low at $1.46 to a day high of $1.53.
90 days $1.41 $2.23
52 weeks $1.41 $3.38

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jan 17, 2025 $1.53 $1.53 $1.46 $1.48 213 813
Jan 16, 2025 $1.64 $1.64 $1.51 $1.51 206 563
Jan 15, 2025 $1.72 $1.77 $1.60 $1.64 235 446
Jan 14, 2025 $1.74 $1.80 $1.66 $1.68 161 208
Jan 13, 2025 $1.83 $1.89 $1.65 $1.68 261 672
Jan 10, 2025 $1.93 $1.93 $1.82 $1.85 125 259
Jan 08, 2025 $2.03 $2.03 $1.88 $1.93 210 194
Jan 07, 2025 $2.19 $2.22 $2.09 $2.10 399 285
Jan 06, 2025 $1.79 $2.23 $1.76 $2.13 822 786
Jan 03, 2025 $1.80 $1.80 $1.66 $1.68 325 432
Jan 02, 2025 $1.78 $1.84 $1.77 $1.81 100 444
Dec 31, 2024 $1.88 $1.95 $1.77 $1.80 384 031
Dec 30, 2024 $1.45 $1.82 $1.45 $1.82 778 441
Dec 27, 2024 $1.51 $1.59 $1.41 $1.41 127 158
Dec 26, 2024 $1.56 $1.59 $1.51 $1.51 94 180
Dec 24, 2024 $1.57 $1.61 $1.53 $1.56 7 303
Dec 23, 2024 $1.59 $1.62 $1.57 $1.57 19 862
Dec 20, 2024 $1.58 $1.64 $1.53 $1.64 87 836
Dec 19, 2024 $1.62 $1.62 $1.58 $1.59 73 882
Dec 18, 2024 $1.69 $1.72 $1.60 $1.63 40 918
Dec 17, 2024 $1.72 $1.78 $1.69 $1.71 63 069
Dec 16, 2024 $1.76 $1.77 $1.70 $1.73 55 395
Dec 13, 2024 $1.82 $1.87 $1.74 $1.76 65 964
Dec 12, 2024 $1.90 $1.93 $1.83 $1.85 32 371
Dec 11, 2024 $1.95 $1.99 $1.90 $1.90 26 386

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use CLLS stock historical prices to predict future price movements?
Trend Analysis: Examine the CLLS stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the CLLS stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!
ABOUT CELLECTIS S.A.
Cellectis S.A.
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL...
GOLDEN STAR
Ticker Change Signal Date
H
HYLS
$41.55
0.289% Jan 15
ROIC
$17.41
0.230% Jan 15
V
VGSH
$58.23
0.0515% Jan 15
F
FALN
$26.87
0.447% Jan 15
F
FTSM
$59.87
0.0668% Jan 15

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE